Banca Ifis Shares Fall 13.2% After Bank of Italy Inspection Findings

Key Facts

Banca Ifis shares were trading down 13.2% at €12.17 at 11:31 a.m. Milan time on September 25, 2026, according to Borsa Italiana. The decline followed the bank's announcement of a Bank of Italy inspection that reached a partly adverse assessment and called for remedies. The supervisor also opened a process to determine additional capital requirements, which could change how much capital the lender has available for growth or distributions. The bank had received the inspection report on September 23 before disclosing its details. The market question is the size of any further credit and capital costs while Banca Ifis pursues its illimity merger and restructuring plans.

The Bank of Italy conducted a broad inspection of Banca Ifis from January through June 2026, according to two reports of the bank's announcement. The findings covered anti-money-laundering controls, information-technology risk, operational security, securitizations, credit processes and purchased nonperforming loans. Internal controls, governance and the sustainability of the business model were also cited, making the response broader than one procedural fix. That scope means costs could emerge in systems, management and oversight as well as loan valuations. Investors need to understand the extent of those changes to distinguish a temporary expense from a continuing drag on earnings.

The supervisor requested an anti-money-laundering and compliance plan, together with a prudential remedy plan covering governance and stronger second-line controls. The requested work also includes revisions to credit, nonperforming-loan and securitization processes, tighter technology-risk and operational-security management, and a new group business plan. A process to set additional capital requirements is due to conclude within 90 days, while the bank has 45 days to submit documents and arguments. Two sanctions proceedings have also begun against the bank; proceedings are not final penalties. These tracks carry different implications for shareholders because remedy plans test execution, while a capital decision could reduce resources available for other uses.

The inspection can affect the share price through loan valuations and regulatory capital. If revised loan classifications or valuations require more provisions, profit could fall and the capital base available to absorb risk could weaken. A higher required capital threshold would also narrow the buffer, even without an immediate new loss. The potential cost is therefore not limited to any eventual fine; loan adjustments or the resources needed to carry out remedies could matter more to valuation. The bank said it would quantify the effect of loan-classification and valuation changes after completing work begun by its board on September 24.

First-half results show why the possibility of further provisions commands attention. Banca Ifis reported €8 million of net profit for the first half of 2026 after including about €30 million of valuation adjustments and provisions linked to an internal review following the inspection. Credit costs for the period were €83.6 million, a line that directly connects loan assessments with earnings. Those figures belong to an already reported period and do not establish the size of any additional charge from the final report. The next valuation question is whether the remedy remains within costs already absorbed or requires new provisions.

The group's common equity tier one, or CET1, ratio stood at 13.4% on June 30, 2026, against regulatory requirements of 9.9% at that date. That comparison indicates a buffer then but does not establish its size after any asset revaluation or decision on higher requirements. The bank also reported about €2.1 billion of liquidity at the end of June, a resource separate from regulatory capital and no substitute for it. For shareholders, the inspection's effect depends on how much capacity remains for growth and distributions after new costs. A prospective buyer or seller must distinguish the published capital ratio from the threshold the supervisor may ultimately impose.

Alongside the inspection risk, Banca Ifis received full and unconditional Bank of Italy approval on September 23 to merge illimity Bank into the group. It expects to complete the merger by the end of 2026 and recognize about €70 million of deferred tax assets associated with it. The bank also retained its target of €75 million in annual synergies from 2027, a goal dependent on execution. Merger approval allows the transaction to proceed while the inspection findings require separate remedies. Investors therefore need to weigh expected integration benefits against remediation costs and any increase in capital requirements, without treating targeted savings as earnings already realized.

A planned sale of the nonperforming-loan business is advancing as Banca Ifis changes its business mix. The bank said it received nonbinding bids for the entire operation on September 24 and moved to the second stage of the competitive process. It aims to sign a binding offer by the end of 2026, subject to the necessary legal approvals, and has not announced a final sale price. The proceeds and terms could affect available capital and the shape of earnings after the business leaves the group. For shareholders, net proceeds will matter alongside whether they offset the sold business's income or help absorb a higher supervisory capital requirement.

The disclosure coincided with a leadership change: the board accepted Frederik Geertman's resignation and appointed Raffaele Zingone chief executive with immediate effect. It named Fabio Lanza general manager, subject to a favorable regulatory fitness assessment before that appointment takes effect. The new team faces the simultaneous tasks of carrying out remedies, integrating illimity and selling the loan business. The appointments' financial significance will depend on whether management can quantify loan adjustments, present an executable business plan and complete the announced transactions. Those steps matter because supervisory decisions, deal terms and future earnings together determine the capital available after restructuring.

The next supervisory step is the bank's opportunity to submit documents and arguments within 45 days, followed by a decision on additional capital requirements within the announced maximum of 90 days. Banca Ifis is scheduled to approve third-quarter results on November 11, 2026, an occasion that may provide an update on credit reviews and remedial work. Completion of the illimity merger and a binding bid for the nonperforming-loan business remain targets for the end of 2026. Disclosures on the size of adjustments, the sale value and the timing of savings would help investors assess future earnings and capital. Larger provisions or higher capital requirements would change the balance between remediation costs and the merger's expected benefits.